Liu Yang, Liu Tianqing, Fan Xiubo, Ma Xuehu, Cui Zhanfeng
Stem Cell and Tissue Engineering Laboratory, Dalian University of Technology, Dalian 116023, China.
J Biotechnol. 2006 Jul 25;124(3):592-601. doi: 10.1016/j.jbiotec.2006.01.020. Epub 2006 Mar 2.
Expansion of umbilical cord blood mononuclear cells (UCB MNCs) was carried out in a rotating wall vessel (RWV) bioreactor and tissue culture flasks (T-flasks) in serum-containing medium supplemented with relatively low doses of purified recombinant human cytokines (5.33 ng/ml IL-3, 16 ng/ml SCF, 3.33 ng/ml G-CSF, 2.13 ng/ml GM-CSF, 7.47 ng/ml FL and 7.47 ng/ml TPO) for 8 days. The cell density, pH and osmolality of the culture medium in the two culture systems were measured every 24h. Flow cytometric assay for CD34+ cells was carried out at 0, 144 and 197 h and methylcellulose colony assays were performed at 0, 72, 144 and 197 h. The pH and osmolality of the medium in the two culture systems were maintained in the proper ranges for hematopoietic stem cells (HSCs) and progenitors culture. The RWV bioreactor, combined with a cell-dilution feeding protocol, was efficient to expand UCB MNCs. At the end of 200 h culture, the total cell number was multiplied by 435.5+/-87.6 times, and CD34+ cells 32.7+/-15.6 times, and colony-forming units of granulocyte-macrophage (CFU-GM) 21.7+/-4.9 times. While in T-flasks, however, total cells density changed mildly, CD34+ cells and CFU-GM decreased in number. It is demonstrated that the RWV bioreactor can provide a better environment for UCB MNCs expansion, enhance the contact between HSCs and accessory cells and make the utilization of cytokines more effective than T-flask.
在含有相对低剂量纯化重组人细胞因子(5.33 ng/ml白细胞介素-3、16 ng/ml干细胞因子、3.33 ng/ml粒细胞集落刺激因子、2.13 ng/ml粒细胞-巨噬细胞集落刺激因子、7.47 ng/ml促纤维细胞生长因子和7.47 ng/ml血小板生成素)的含血清培养基中,在旋转壁式生物反应器(RWV)和组织培养瓶(T瓶)中进行脐带血单个核细胞(UCB MNCs)的扩增培养8天。每24小时测量两种培养系统中培养基的细胞密度、pH值和渗透压。在0、144和197小时进行CD34+细胞的流式细胞术检测,并在0、72、144和197小时进行甲基纤维素集落检测。两种培养系统中培养基的pH值和渗透压维持在适合造血干细胞(HSCs)和祖细胞培养的适当范围内。RWV生物反应器结合细胞稀释补料方案,能够有效地扩增UCB MNCs。在培养200小时结束时,总细胞数增加了435.5±87.6倍,CD34+细胞增加了32.7±15.6倍,粒细胞-巨噬细胞集落形成单位(CFU-GM)增加了21.7±4.9倍。然而,在T瓶中,总细胞密度变化不大,CD34+细胞和CFU-GM数量减少。结果表明,RWV生物反应器能够为UCB MNCs的扩增提供更好的环境,增强造血干细胞与辅助细胞之间的接触,并使细胞因子的利用比T瓶更有效。